Navigation Links
Grupo Casa Saba Announces Quarterly Earnings Report 2Q09
Date:7/27/2009

of 2008.

CASH AND CASH EQUIVALENTS

Cash and cash equivalents at the end of the second quarter of 2009 was $199.15 million.

COMPREHENSIVE COST OF FINANCING

During the period, GCS's comprehensive cost of financing (CCF) rose to $58.63 million. This was primarily due to an increase in the amount of interest income paid.

These interest payments are related to the long-term credit that was obtained as a result of the acquisition in Brazil as well as the interest that was generated from the utilization of short-term credits for our operations in both Mexico and Brazil.

OTHER EXPENSES (INCOME)

During the second quarter of 2009, the Company registered an income of $2.26 million in other expenses (income). The expenses (income) from this line item were derived from activities that are distinct from the company's everyday business operations.

TAX PROVISIONS

During the second quarter, tax provisions rose to $43.72 million, $55.04 million of which were related to income tax payments and ($11.32) million were attributed to deferred income tax.

NET INCOME

GCS's net income for the second quarter was $147.03 million, a decrease of 30.02% compared to the second quarter of 2008.

The net margin for the period was 1.94%, a decline from the 3.02% net margin registered during the second quarter of 2008.

WORKING CAPITAL

During the second quarter of 2009, our accounts receivable days increased by 7.2 days from 2Q08 to reach 67.8 days. In addition, our accounts payable days rose by 4.0 days versus 2Q08, to reach 52.0 days. Finally, our inventory days were 55.0 days, an increase of 1.1 days compared to the same period of the previous year.

    Contacts:

    GRUPO CASA SABA
    Patrik Zielinski
    +52 (55) 5284-6623
    '/>"/>
SOURCE Grupo Casa Saba
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Grupo Casa Saba Announces Third Quarter 2007 Results
2. Grupo Casa Saba Announces Fourth Quarter 2007 Results
3. Grupo Casa Saba Announces Sales and Operating Income Increased 14.05% and 13.45%, Respectively
4. Grupo IMO Hosts Symposium on Use of TomoTherapy for Stereotactic Radiosurgery and Stereotactic Body Radiation Procedures : Experts Detail HiArt Platform Advantages for Treatment of Brain, Lung, Pancreatic and Metastatic Cancers
5. Grupo Casa Saba Quarterly Earnings Report 3Q08
6. Grupo Casa Saba Announces 4Q08 Earnings Results
7. Grupo Aeroportuario del Pacifico, S.A.B. de C.V. Announcement Regarding Swine Flu Virus
8. Genomma Lab Internacional Acquires Brands Flor de Naranja Sanborns(MR), Teatrical and Henna Egipcia From Grupo Sanborns
9. Grupo Salinas, Fundacion Azteca and Mexicos Environmental Ministry Present Ciudades Mas Limpias de Mexico and Recicla 2009 Anti-Litter and Recycling Contests
10. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
11. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...TO,Nov.25/PRNewswire/-SentinelleMedicalInc.,aleadi...tionsoftwarelaunchesasuiteofnewleadingedgeclinical...atformatthisyear,sRadiologicalSocietyofNorthAmeric...oth5800,HallA).Theapplicationsleveragetheuniquehig...Iimagingcoilsandsupportmultipleimagingmodalitiesfo...
(Date:11/25/2009)...GELES,Nov.25/PRNewswire-USNewswire/--TheBlackAIDSI...rmineexecutiveleadershipfor2010. ,, ThenewBoard...iesinpublicpolicy,law,finance,governmenthealthprog...dalsocomesfromawiderangeofpersonalbackgroundsinclu...ingwithHIVthemselves,andrepresentingmultipleagegro...
(Date:11/25/2009)...urvivors of testicular cancer who were treated wit...e effects, including neurological side effects and...ated with chemotherapy, according to a new study p... National Cancer Institute . , Marianne Brydy, M...ersity Hospital, in Bergen, Norway, and colleagues...
(Date:11/25/2009)... increase blood pressure? This simple question ha...s. New Stress-related gene Modulates High Blood P... pressure? This simple question has been the focu...earch has for the first time established a link be...ure response to stress in mice as well as humans. ...
(Date:11/25/2009)... Evaluation and treatment clinics to r...oodstock (Vocus) November 25, 2009 -- Centegra Hea...nes and H1N1 vaccine shots at four Centegra Primar...pment of vaccine has arrived. The clinics are at C...cHenry and will be open as follows: ,   ...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...a,AFL-CIO President William George and Secretary T...ppointment in the latest decisions by,Representati...er to play,partisan politics with health insurance...ntatives Peterson, Pitts and Shuster could have ch...
...nson,Pharmaceutical Research & Development, L.L.C....ation (NDA) to the U.S. Food and Drug,Administrati...lease (IR),tablets, an investigational oral analge... each year as a result of injuries or,surgeries, a...
...ific (NYSE: BSX ),today issued the following stat... Scientific Officer, on an article in the New Engl...Bare-Metal and Drug-Eluting Stents for,Off-Label I...s the latest,in a series of studies that have led ...
... five years without anti-rejection drugs , ...es that allow organ transplant recipients to stop ...ng to come to fruition. , "The next stage in the d...s of the lifelong immunosuppressive drugs," said D...
...nthesis method based on a catalyst worth many time...ient and economical method than traditional ones f...rmaceutical compounds is described by its Universi...ium Technologies, LLC in Buffalo, has the potentia...
...ight to site of blood clot, study reports , ...s that attack blood clots directly in the brain ma...nd to the standard treatment using clot-busting dr...Fla. , Ischemic strokes -- which account for about...
Other Medicine News:Health News:Pennsylvania AFL-CIO Decries Shameful Votes Again by Representatives John Peterson, Joe Pitts and Bill Shuster, Against Children's Health Care 2Health News:New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets 2Health News:New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets 3Health News:New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets 4Health News:Boston Scientific Comments on New England Journal of Medicine Article 2Health News:Boston Scientific Comments on New England Journal of Medicine Article 3Health News:New Therapies Could Change Organ Transplants 2Health News:New Therapies Could Change Organ Transplants 3Health News:New method enables design, production of extremely novel drugs 2Health News:New method enables design, production of extremely novel drugs 3Health News:Advanced Therapy Aids Stroke Patients 2Health News:Advanced Therapy Aids Stroke Patients 3
(Date:11/25/2009)...OHANNESBURG,November25/PRNewswire/--,iThembaPharma...dtoday,thattheyhavesignedacollaborativeagreementto...,sworldclasscomputationalchemistryandleaddiscovery...ntoprovidemedicinaland,syntheticchemistrysupportto...tnetwork.iThembaPharmaceuticalsandPyxisDiscovery,a...
(Date:11/24/2009)...wire/-- ,, WHAT:RomHoubens,aBelgianmanthoughtto...sactuallyfullyconsciousandawakeduringthattimeandwa...EyeMaxwasfeaturedinthesegmenttoillustratehowpeople...mmunication. ,, WHEN:GoodMorningAmerica-- Tuesd....com ,, WHO:RomHoubenswasanengineeringstude...
(Date:11/24/2009)...re-FirstCall/--AnadysPharmaceuticals,Inc.(Nasdaq: ...alPiperJaffrayHealthcareConferenceonTuesday,Decemb...beingheldatTheNewYorkPalaceHotel.SteveWorland,Ph.D...ovideanoverviewofAnadysanditsclinicaldevelopmentpr...tionwillbesimultaneouslywebcastandcanbeaccessedont...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Starpharma Announces 2415 6 million Capital Raising 6366 1Starpharma Announces 2415 6 million Capital Raising 6366 2Starpharma Announces 2415 6 million Capital Raising 6366 3Can EP4 agonist alleviate gastric lesions 3F 61617 1Antifibrotic effects of green tea 61613 1
...Surgery(TM) Platform Product Candidate in Clinical...ay announced,that it is enrolling patients in a Ph... PharmacoSurgery(TM) product candidate, for use du...undergoing age-related,cataract extraction with le...tudy., "With the initiation of this study, all th...
...ing Technology Could Have Widespread Use in Improv...nimals from Extinction, MT. LAUREL, N.J., Sept. 8...with freeze-dried cells is possible for the first,...t issue of the research,journal PLos One. The comp...ed in the study., Cloning starts when an egg with...
Other Medicine Technology:Omeros Announces Patient Enrollment in Phase 1/Phase 2 Study of OMS302 2New Study Shows Cloning from Dried Cells Now Possible 2
Replacement Bulb: HBO 50W/AC/L2
Replacement Bulb: ESA/FHD
Replacement Bulb: EJA
Replacement Bulb: EFM
Medicine Products: